Toll Free: 1-888-928-9744

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea

Published: Mar 31, 2014 | Pages: 261 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in South Korea. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of South Korea. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.
In 2013, South Korea's population was approximately at 50.2 million. It has one of the world's highest population densities. The South Korean government has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country's future growth. To support this industry, the South Korean regulatory authorities recently made changes to the regulatory bodies overseeing the pharmaceutical and wider medical sectors, to provide a transparent, strong and efficient regulatory system to facilitate faster approval of pharmaceutical products and medical devices. The South Korean pharmaceutical market is one of the largest in Asia, estimated to be worth $18.6 billion in 2013 and expected to reach $24.3 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 3.9% over the 2008-2020 period. The medical device market was valued at $3.3 billion in 2008 and is expected to reach approximately $6.3 billion by 2020, at a projected CAGR of 5.5%. These positive trends can primarily be attributed to:

An increasing elderly population in South Korea, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices.

Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in South Korea, and includes - 
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Dong-A Pharmaceutical, Yuhan Corporation, Green Cross Corporation, Hanmi Pharmaceutical, and Daewoong Pharmaceuticals) and the medical device market (Siemens Healthcare, Abbott Laboratories, Baxter International, F-Hoffman La Roche and GE Healthcare)
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the South Korean healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to - 
- Develop business strategies by understanding the trends shaping and driving South Korea's healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in South Korea's healthcare market
 Table of Contents
1 Table of Contents 6
1.1 List of Tables 9
1.2 List of Figures 14
2 Introduction 19
2.1 GlobalData Report Guidance 19
3 Overview of the Pharmaceutical and Medical Device Markets 20
3.1 Pharmaceutical Market 20
3.1.1 Market Overview 20
3.1.2 Pharmaceutical Imports and Exports 24
3.1.3 Supply Channels 25
3.1.4 Market Segments 25
3.1.5 Major Therapeutic Areas 32
3.1.6 Major Players 35
3.2 Medical Device Market 67
3.2.1 Market Overview 67
3.2.2 Overview of Top Five Segments 70
3.2.3 Major Players 82
3.3 Market Drivers and Barriers 122
3.3.1 Drivers 122
3.3.2 Barriers 123
4 Market Access 125
4.1 Reimbursement and Payer Landscape 125
4.1.1 Healthcare System 125
4.1.2 Reimbursement Process 127
4.1.3 Overview of Insurance Providers 130
4.1.4 Patient Share in Healthcare Spending 135
4.1.5 Pricing Policies 136
4.2 Regulatory Landscape 140
4.2.1 Overview of Regulatory Agencies 140
4.2.2 Drug Approval Process 144
4.2.3 New Device Approval Process 145
4.2.4 Licensing Process for Manufacturing 152
4.2.5 Licensing Process for Exports and Imports 153
4.2.6 Intellectual Property Rights Landscape 155
4.2.7 Clinical Trial Regulations 157
4.2.8 Pharmaceutical Advertising Regulations 159
4.2.9 Pharmacy Regulations 160
4.2.10 Labeling and Packing Regulations 162
5 Country Analysis 163
5.1 Political Environment 163
5.1.1 Political Structure 163
5.1.2 Domestic Political Situation 165
5.1.3 Analysis of the Current Political Environment 166
5.1.4 Healthcare Policy Initiatives 168
5.2 Economic Landscape 170
5.3 Economic Indicators 173
5.3.1 Gross Domestic Product 173
5.3.2 Gross National Income 178
5.3.3 Inflation 179
5.3.4 Currency Exchange Rate 181
5.3.5 Foreign Direct Investment 182
5.3.6 Foreign Exchange Reserves 183
5.3.7 Trade Balance 185
5.3.8 Government Structural Balance 187
5.3.9 Government Net Debt 188
5.3.10 External Debt 189
5.3.11 Major Industries 190
5.4 Demographics 192
5.4.1 Population 192
5.4.2 Education and Literacy 208
5.4.3 Employment 209
5.4.4 Disease Burden 210
5.5 Healthcare Infrastructure 212
5.5.1 Healthcare Facilities 212
5.5.2 Healthcare Infrastructure 214
5.5.3 Healthcare Parameters 216
5.5.4 Environmental Health 218
5.5.5 Healthcare Personnel 222
5.6 Healthcare Expenditure 225
5.6.1 Overview 225
5.6.2 Major Components of Healthcare Spending 227
5.6.3 Shares of the Public and Private Sectors 228
5.6.4 Spending in Pharmaceutical R&D 229
5.7 Trade Associations 231
5.7.1 Korean Pharmaceutical Association 231
5.7.2 Korea Pharmaceutical Manufacturers Association 232
5.7.3 Korean Hospital Association 232
5.8 Trade Fairs 232
6 Opportunities and Challenges 234
6.1 Opportunities 234
6.2 Challenges 235
7 Appendix 237
7.1 Abbreviations 237
7.2 Bibliography 242
7.3 Research Methodology 258
7.3.1 Coverage 258
7.3.2 Secondary Research 259
7.3.3 Forecasts 260
7.3.4 Expert Panel 260
7.4 Disclaimer 260
List of Tables 
Table 1: Pharmaceutical Market, South Korea, Revenue ($bn), 2008-2013 22
Table 2: Pharmaceutical Market, South Korea, Revenue Forecast ($bn), 2014-2020 23
Table 3: Pharmaceutical Market, South Korea, Imports and Exports ($bn), 2008-2013 24
Table 4: Pharmaceutical Market, South Korea, Generic Pharmaceutical Market ($bn), 2008-2013 26
Table 5: Pharmaceutical Market, South Korea, Biologics Market, Production ($bn), 2008-2013 28
Table 6: Pharmaceutical Market, South Korea, Biopharmaceutical Market by Type (%), 2010 29
Table 7: Pharmaceutical Market, South Korea, Prescription and OTC Drugs Market Share (%), 2008-2013 31
Table 8: Pharmaceutical Market, South Korea, Major Therapeutic Areas, Expenditure ($bn), 2007 33
Table 9: Dong-A Pharmaceuticals, Global, Major Products, 2014 36
Table 10: Dong-A Pharmaceuticals, Global, Late-stage Pipeline, 2014 36
Table 11: Yuhan Corporation, Global, Major Products, 2014 41
Table 12: Green Cross Holdings Corporation, Global, Major Products, 2014 48
Table 13: Green Cross Holdings Corporation, Global, Late-stage Pipeline, 2014 49
Table 14: Hanmi Pharmaceuticals, Global, Major Products, 2014 55
Table 15: Hanmi Pharmaceuticals, Global, Late-Stage Pipeline, 2014 56
Table 16: Daewoong Pharmaceuticals, Global, Major Products, 2014 61
Table 17: Daewoong Pharmaceuticals, Global, Late-Stage Pipeline, 2014 62
Table 18: Medical Device Market, South Korea, Revenue ($bn), 2008-2013 68
Table 19: Medical Device Market, South Korea, Revenue Forecast ($bn), 2014-2020 69
Table 20: Medical Device Market, South Korea, Revenue by Segment ($m), 2012 70
Table 21: Medical Device Market, South Korea, Ophthalmic Devices, Revenue ($m), 2008-2013 72
Table 22: Medical Device Market, South Korea, Ophthalmic Devices Market, Sales Trends for Major Players, 2012* 72
Table 23: Medical Device Market, South Korea, In Vitro Diagnostics Devices, Revenue ($m), 2008-2013 74
Table 24: Medical Device Market, South Korea, In Vitro Diagnostics Devices, Sales Trends for Major Players, 2012* 75
Table 25: Medical Device Market, South Korea, Nephrology and Urology Devices, Revenue ($m), 2008-2013 77
Table 26: Medical Device Market, South Korea, Nephrology and Urology Devices, Sales Trends for Major Players, 2012* 77
Table 27: Medical Device Market, South Korea, Orthopedic Devices, Revenue ($m), 2008-2013 79
Table 28: Medical Device Market, South Korea, Orthopedic Devices, Sales Trends for Major Players, 2012* 79
Table 29: Medical Device Market, South Korea, Dental Devices, Revenue ($m), 2008-2013 81
Table 30: Medical Device Market, South Korea, Dental Devices, Sales Trends for Major Players, 2012* 81
Table 31: Medical Device Market, South Korea, Major Players, 2012 82
Table 32: Siemens Healthcare, Global, Major Products, 2014 83
Table 33: Abbott Laboratories, Global, Major Products, 2014 91
Table 34: Abbott Laboratories, Global, Major products, 2014 92
Table 35: Baxter International, Global, Major Products, 2012 99
Table 36: F. Hoffmann-La Roche, Global, Major Products, 2013 107
Table 37: F. Hoffmann-La Roche, Global, Late-stage Pipeline, 2014 107
Table 38: National Health Insurance Expenditure, South Korea, Expenditure ($bn), 2008-2012 133
Table 39: Private and Public Healthcare Schemes, South Korea, 2014 134
Table 40: Co-payments, South Korea, 2014 135
Table 41: Healthcare Spending, South Korea, Out-of-Pocket Expenditure (%), 2008-2013 136
Table 42: Healthcare System, Medical Device Classification and Approval Process, South Korea, 2014 147
Table 43: Healthcare System, Patent Application Fees (KRW) ($), South Korea, 2014 156
Table 44: Healthcare System, Trademark Application Fees (KRW) ($), South Korea, 2014 157
Table 45: Economic Indicators, South Korea, Gross Domestic Product per Capita ($), 2008-2013 174
Table 46: Economic Indicators, South Korea, Gross Domestic Product per Capita Forecast ($), 2014-2020 175
Table 47: Economic Indicators, South Korea, Gross Domestic Product Annual Growth (%), 2008-2013 176
Table 48: Economic Indicators, South Korea, Gross Domestic Product Annual Growth Forecast (%), 2014-2020 177
Table 49: Economic Indicators, South Korea, Gross National Income per Capita ($), 2008-2013 178
Table 50: Economic Indicators, South Korea, Average Consumer Price Index, 2008-2013 179
Table 51: Economic Indicators, South Korea, Average Consumer Price Annual Change (%), 2008-2013 180
Table 52: Economic Indicators, South Korea, Currency Exchange Rate (KRW/$), 2008-2013 181
Table 53: Economic Indicators, South Korea, Foreign Direct Investment ($bn), 2008-2013 183
Table 54: Economic Indicators, South Korea, Foreign Exchange Reserves ($bn), 2008-2013 184
Table 55: Economic Indicators, South Korea, Exports of Goods and Services ($bn), 2008-2013 186
Table 56: Economic Indicators, South Korea, Imports of Goods and Services ($bn), 2008-2013 186
Table 57: Economic Indicators, South Korea, Government Structural Balance ($bn), 2008-2013 187
Table 58: Economic Indicators, South Korea, General Government Net Debt (% of GDP), 2008-2013 188
Table 59: Economic Indicators, South Korea, General Government Net Debt, Forecast (% of GDP), 2014-2020 189
Table 60: Economic Indicators, South Korea, External Debt ($bn), 2008-2013 190
Table 61: Economic Indicators, South Korea, Major Industries, Annual Sales ($bn), 2011 and 2012 191
Table 62: Demographics, South Korea, Population (million), 2008-2013 192
Table 63: Demographics, South Korea, Population Forecast (million), 2014-2020 193
Table 64: Demographics, South Korea, Population, Urban and Rural Population Share (%), 2008-2013 194
Table 65: Demographics, South Korea, Population, Urban and Rural Population Share, Forecast (%), 2014-2020 195
Table 66: Demographics, South Korea, Population Distribution by Age Group (%), 2008-2013 196
Table 67: Demographics, South Korea, Population Distribution by Age Group, Forecast (%), 2014-2020 197
Table 68: Demographics, South Korea, Births (per 1,000 Population), 2008-2013 198
Table 69: Demographics, South Korea, Mortality (per 1,000 Population), 2008-2013 199
Table 70: Demographics, South Korea, Major Causes of Mortality, 2012 200
Table 71: Demographics, South Korea, Children <5 Years Age, Mortality Rate (per 1,000 Live Births), 2008-2013 201
Table 72: Demographics, South Korea, Immunization Rate (%), 2008-2013 202
Table 73: Demographics, South Korea, Major Causes of Male Mortality, 2012 204
Table 74: Demographics, South Korea, Major Causes of Female Mortality, 2012 205
Table 75: Demographics, South Korea, Gender Ratio (M/F), 2008-2013 206
Table 76: Demographics, South Korea, Life Expectancy at Birth (Years), 2008-2013 207
Table 77: Demographics, South Korea, Life Expectancy at Birth, Forecast (Years), 2014-2020 207
Table 78: Demographics, South Korea, Student Enrollment by Level of Education (%), 2008-2013 209
Table 79: Demographics, South Korea, Unemployment Rate (%), 2008-2013 210
Table 80: Demographics, South Korea, Major Diseases, DALYs (per 100,000 Population), 2009 212
Table 81: Healthcare Infrastructure, South Korea, Hospitals, 2008-2013 214
Table 82: Healthcare Infrastructure, South Korea, Beds (per 1,000 Population) by Type of Service, 2008-2013 215
Table 83: Healthcare Infrastructure, South Korea, Diagnostic Equipment (per 1,000,000 Population), 2008-2013 216
Table 84: Healthcare Infrastructure, South Korea, Hospital Beds (per 1,000 Population), 2008-2013 217
Table 85: Healthcare Infrastructure, South Korea, Practicing Physicians (per 1,000 Population), 2008-2013 218
Table 86: Healthcare Infrastructure, South Korea, CO2 Emissions (Million Tons), 2008-2013 220
Table 87: Healthcare Infrastructure, South Korea, CH4 Emissions (Million Tons), 2008-2013 220
Table 88: Healthcare Infrastructure, South Korea, PM10 (gm/m ), 2008-2013 221
Table 89: Healthcare Infrastructure, South Korea, General Practitioners (per 1,000 Population), 2008-2013 223
Table 90: Healthcare Infrastructure, South Korea, Nurses (per 1,000 Population), 2008-2013 224
Table 91: Healthcare Infrastructure, South Korea, Dentists (per 1,000 Population), 2008-2013 225
Table 92: Healthcare Expenditure, South Korea, Healthcare Expenditure (% of GDP), 2008-2013 226
Table 93: Healthcare Expenditure, South Korea, Current Expenditure on Health by Type of Services (%), 2011 227
Table 94: Healthcare Expenditure, South Korea, Healthcare Expenditure, Public-Private Share (%), 2008-2013 229
Table 95: Healthcare Expenditure, South Korea, Pharmaceutical R&D Expenditure (Percentage of Sales), 2008-2013 230
Table 96: Major Healthcare Trade Fairs, South Korea, 2014 233 


List of Figures
Figure 1: Pharmaceutical Market, South Korea, Revenue ($bn), 2008-2013 22
Figure 2: Pharmaceutical Market, South Korea, Revenue Forecast ($bn), 2014-2020 23
Figure 3: Pharmaceutical Market, South Korea, Imports and Exports ($bn), 2008-2013 24
Figure 4: Pharmaceutical Market, South Korea, Generic Pharmaceutical Market ($bn), 2008-2013 26
Figure 5: Pharmaceutical Market, South Korea, Biologics Market, Production ($bn), 2008-2013 28
Figure 6: Pharmaceutical Market, South Korea, Biopharmaceutical Market by Type (%), 2010 29
Figure 7: Pharmaceutical Market, South Korea, Prescription and OTC Drugs Market Share (%), 2008-2013 31
Figure 8: Pharmaceutical Market, South Korea, Major Therapeutic Areas, Expenditure ($bn), 2007 32
Figure 9: Medical Device Market, South Korea, Revenue ($bn), 2008-2013 68
Figure 10: Medical Device Market, South Korea, Revenue Forecast ($bn), 2014-2020 69
Figure 11: Medical Device Market, South Korea, Revenue by Segment ($m), 2012 70
Figure 12: Medical Device Market, South Korea, Ophthalmic Devices, Revenue ($m), 2008-2013 71
Figure 13: Medical Device Market, South Korea, Ophthalmic Devices, Sales Trends for Major Players ($m), 2008-2012* 72
Figure 14: Medical Device Market, South Korea, In Vitro Diagnostics Devices, Revenue ($m), 2008-2013 74
Figure 15: Medical Device Market, South Korea, In Vitro Diagnostics Devices, Sales Trends for Major Players ($m), 2012* 75
Figure 16: Medical Device Market, South Korea, Nephrology and Urology Devices, Revenue ($m), 2008-2013 76
Figure 17: Medical Device Market, South Korea, Nephrology and Urology Devices, Sales Trends for Major Players ($m), 2012* 77
Figure 18: Medical Device Market, South Korea, Orthopedic Devices, Revenue ($m), 2008-2013 78
Figure 19: Medical Device Market, South Korea, Orthopedic Devices, Sales Trends for Major Players ($m), 2012* 79
Figure 20: Medical Device Market, South Korea, Dental Devices, Revenue ($m), 2008-2013 80
Figure 21: Medical Device Market, South Korea, Dental Devices, Sales Trends for Major Players ($m), 2012* 81
Figure 22: Medical Device Market, South Korea, Major Players, Revenue ($m), 2012 82
Figure 23: Healthcare Market, South Korea, Drivers and Barriers, 2014 124
Figure 24: Health Security System, South Korea, 2014 126
Figure 25: Evolution of the Healthcare System, South Korea, 1963-2003 126
Figure 26: Healthcare System, South Korea, 2014 127
Figure 27: Reimbursement Approval Process for Pharmaceutical Products, South Korea, 2014 129
Figure 28: Reimbursement Approval Process for Medical Devices, South Korea, 2014 130
Figure 29: Structure of National Health Insurance, South Korea, 2014 132
Figure 30: National Health Insurance Expenditure, South Korea, Expenditure ($bn), 2008-2012 133
Figure 31: Healthcare Spending, South Korea, Out-of-Pocket Expenditure (%), 2008-2013 136
Figure 32: Drug Pricing and Reimbursement Decision-making Process, South Korea, 2014 139
Figure 33: Healthcare System, Offices for Medical Devices, South Korea, 2014 141
Figure 34: Healthcare System, Organization of Ministry of Food and Drug Safety, South Korea, 2014 142
Figure 35: Healthcare System, Organization of National Institute of Food and Drug Safety Evaluation, South Korea, 2014 143
Figure 36: Healthcare System, Drug Approval Process, South Korea, 2014 145
Figure 37: Healthcare System, Medical Pre-market Approval Pathway Process, South Korea, 2014 150
Figure 38: Healthcare System, Clinical Trial Approval Process, South Korea, 2014 158
Figure 39: Economic Indicators, South Korea, Gross Domestic Product per Capita ($), 2008-2013 174
Figure 40: Economic Indicators, South Korea, Gross Domestic Product per Capita Forecast ($), 2014-2020 175
Figure 41: Economic Indicators, South Korea, Gross Domestic Product Annual Growth (%), 2008-2013 176
Figure 42: Economic Indicators, South Korea, Gross Domestic Product Annual Growth Forecast (%), 2014-2020 177
Figure 43: Economic Indicators, South Korea, Gross National Income per Capita ($), 2008-2013 178
Figure 44: Economic Indicators, South Korea, Average Consumer Price Index, 2008-2013 179
Figure 45: Economic Indicators, South Korea, Average Consumer Price Annual Change (%), 2008-2013 180
Figure 46: Economic Indicators, South Korea, Currency Exchange Rate (KRW/$), 2008-2013 181
Figure 47: Economic Indicators, South Korea, Foreign Direct Investment ($bn), 2008-2013 183
Figure 48: Economic Indicators, South Korea, Foreign Exchange Reserves ($bn), 2008-2013 184
Figure 49: Economic Indicators, South Korea, Exports of Goods and Services ($bn), 2008-2013 185
Figure 50: Economic Indicators, South Korea, Imports of Goods and Services ($bn), 2008-2013 186
Figure 51: Economic Indicators, South Korea, Government Structural Balance ($bn), 2008-2013 187
Figure 52: Economic Indicators, South Korea, General Government Net Debt (% of GDP), 2008-2013 188
Figure 53: Economic Indicators, South Korea, General Government Net Debt, Forecast (% of GDP), 2014-2020 189
Figure 54: Economic Indicators, South Korea, External Debt ($bn), 2008-2013 190
Figure 55: Economic Indicators, South Korea, Major Industries, Annual Sales ($bn), 2011 and 2012 191
Figure 56: Demographics, South Korea, Population (million), 2008-2013 192
Figure 57: Demographics, South Korea, Population Forecast (million), 2014-2020 193
Figure 58: Demographics, South Korea, Population, Urban and Rural Population Share (%), 2008-2013 194
Figure 59: Demographics, South Korea, Population, Urban and Rural Population Share, Forecast (%), 2014-2020 195
Figure 60: Demographics, South Korea, Population Distribution by Age Group (%), 2008-2013 196
Figure 61: Demographics, South Korea, Population Distribution by Age Group, Forecast (%), 2014-2020 197
Figure 62: Demographics, South Korea, Births (per 1,000 Population), 2008-2013 198
Figure 63: Demographics, South Korea, Mortality (per 1,000 Population), 2008-2013 199
Figure 64: Demographics, South Korea, Major Causes of Mortality, 2012 200
Figure 65: Demographics, South Korea, Children <5 Years, Mortality Rate (per 1,000 Live Births), 2008-2013 201
Figure 66: Demographics, South Korea, Immunization Rate (%), 2008-2013 202
Figure 67: Demographics, South Korea, Major Causes of Male Mortality ('000), 2012 203
Figure 68: Demographics, South Korea, Major Causes of Female Mortality ('000), 2012 204
Figure 69: Demographics, South Korea, Gender Ratio (M/F), 2008-2013 205
Figure 70: Demographics, South Korea, Life Expectancy at Birth (Years), 2008-2013 206
Figure 71: Demographics, South Korea, Life Expectancy at Birth, Forecast (Years), 2014-2020 207
Figure 72: Demographics, South Korea, Student Enrollment by Level of Education (%), 2008-2013 209
Figure 73: Demographics, South Korea, Unemployment Rate (%), 2008-2013 210
Figure 74: Demographics, South Korea, Major Diseases, DALYs (per 100,000 Population), 2009 211
Figure 75: Healthcare Infrastructure, South Korea, Hospitals, 2008-2013 213
Figure 76: Healthcare Infrastructure, South Korea, Beds (per 1,000 Population) by Type of Service, 2008-2013 214
Figure 77: Healthcare Infrastructure, South Korea, Diagnostic Equipment (per 1,000,000 Population), 2008-2013 215
Figure 78: Healthcare Infrastructure, South Korea, Hospital Beds (per 1,000 Population), 2008-2013 217
Figure 79: Healthcare Infrastructure, South Korea, Practicing Physicians (per 1,000 Population), 2008-2013 218
Figure 80: Healthcare Infrastructure, South Korea, CO2 Emissions (Million Tons), 2008-2013 219
Figure 81: Healthcare Infrastructure, South Korea, CH4 Emissions (Million Tons), 2008-2013 220
Figure 82: Healthcare Infrastructure, South Korea, PM10 (gm/m), 2008-2013 221
Figure 83: Healthcare Infrastructure, South Korea, General Practitioners (per 1,000 Population), 2008-2013 223
Figure 84: Healthcare Infrastructure, South Korea, Nurses (per 1,000 Population), 2008-2013 224
Figure 85: Healthcare Infrastructure, South Korea, Dentists (per 1,000 Population), 2008-2013 225
Figure 86: Healthcare Expenditure, South Korea, Healthcare Expenditure (% of GDP), 2008-2013 226
Figure 87: Healthcare Expenditure, South Korea, Current Expenditure on Health by Type of Services (%), 2011 227
Figure 88: Healthcare Expenditure, South Korea, Healthcare Expenditure, Public-Private Share (%), 2008-2013 228
Figure 89: Healthcare Expenditure, South Korea, Pharmaceutical R&D Expenditure (Percentage of Sales), 2008-2013 230
Figure 90: Healthcare Market, South Korea, Opportunities and Challenges, 2014 236

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global adhesives & sealants market size is expected to reach USD 43.19 billion by 2020, as per a new research report by Radiant Insights, Inc. Strong demand from packaging, construction and automotive industries is expected drive adhesives and sealan

Read More...

Global heat transfer fluids market size is likely to be valued at USD 3.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing demand for for heat recovery management in industries such as metal processing, pharmaceutica

Read More...

Global PP (Polypropylene) nonwoven fabric market size is anticipated to be valued at USD 30.6 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing usage of hygiene products such as incontinence products and baby diapers is

Read More...

Global coated fabrics market size forecast is estimated at USD 22.57 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing production of seat covers & airbags for automobile applications is likely to favor market growth.

Read More...

Global amino acids market size is anticipated to be valued at USD 35.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in animal feed additive demand owing to regulate metabolism in livestock production owing to growi

Read More...
Choose License Type
Single User - US $1995
Multi User - US $3990
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify